Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera

Lukas Ronner; John Mascarenhas; Erin L. Moshier

doi:10.1182/bloodadvances.2019000822

Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera

Lukas Ronner, John Mascarenhas, Erin L. Moshier

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	3010-3012
Number of pages	3
Journal	Blood advances
Volume	3
Issue number	20
DOIs	https://doi.org/10.1182/bloodadvances.2019000822
State	Published - 22 Oct 2019

Access to Document

10.1182/bloodadvances.2019000822

Cite this

@article{383fbe859e514afd872321f7e0e2b4b9,

title = "Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera",

author = "Lukas Ronner and John Mascarenhas and Moshier, {Erin L.}",

note = "Funding Information: Conflict-of-interest disclosure: J.M. receives research funding from Incyte, Novartis, Roche, Promedior, Janssen, PharmaEssentia, and CTI Biopharma; and serves as an advisory board member for Incyte, Roche, Celgene, and PharmaEssentia. The remaining authors declare no competing financial interests.",

year = "2019",

month = oct,

day = "22",

doi = "10.1182/bloodadvances.2019000822",

language = "English",

volume = "3",

pages = "3010--3012",

journal = "Blood advances",

issn = "2473-9529",

publisher = "Elsevier BV",

number = "20",

}

TY - JOUR

T1 - Response to meta-analysis of leukocytosis and thrombosis in essential thrombocythemia and polycythemia vera

AU - Ronner, Lukas

AU - Mascarenhas, John

AU - Moshier, Erin L.

N1 - Funding Information: Conflict-of-interest disclosure: J.M. receives research funding from Incyte, Novartis, Roche, Promedior, Janssen, PharmaEssentia, and CTI Biopharma; and serves as an advisory board member for Incyte, Roche, Celgene, and PharmaEssentia. The remaining authors declare no competing financial interests.

PY - 2019/10/22

Y1 - 2019/10/22

UR - http://www.scopus.com/inward/record.url?scp=85074942026&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2019000822

DO - 10.1182/bloodadvances.2019000822

M3 - Letter

C2 - 31648311

AN - SCOPUS:85074942026

SN - 2473-9529

VL - 3

SP - 3010

EP - 3012

JO - Blood advances

JF - Blood advances

IS - 20

ER -